Dynamics of Hepatitis B Virus Pregenomic RNA in Chronic Hepatitis B Patients With Antiviral Therapy Over 9 Years

Serum hepatitis B virus pregenomic RNA (HBV pgRNA) is a potential biomarker that is correlated with covalently closed circular DNA. The long-term dynamics of HBV pgRNA in patients with chronic hepatitis B need to be explored. One hundred naïve nucleos(t)ide analog-treated patients with chronic hepat...

Full description

Bibliographic Details
Main Authors: Jiali Pan, Yu Tian, Jinghang Xu, Hao Luo, Ning Tan, Yifan Han, Qian Kang, Hongyu Chen, Yuqing Yang, Xiaoyuan Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.851717/full
_version_ 1818015524221616128
author Jiali Pan
Yu Tian
Jinghang Xu
Hao Luo
Ning Tan
Yifan Han
Qian Kang
Hongyu Chen
Yuqing Yang
Xiaoyuan Xu
author_facet Jiali Pan
Yu Tian
Jinghang Xu
Hao Luo
Ning Tan
Yifan Han
Qian Kang
Hongyu Chen
Yuqing Yang
Xiaoyuan Xu
author_sort Jiali Pan
collection DOAJ
description Serum hepatitis B virus pregenomic RNA (HBV pgRNA) is a potential biomarker that is correlated with covalently closed circular DNA. The long-term dynamics of HBV pgRNA in patients with chronic hepatitis B need to be explored. One hundred naïve nucleos(t)ide analog-treated patients with chronic hepatitis B were enrolled to analyze the dynamics of HBV pgRNA over 9 years. The positive rates of HBV pgRNAs declined gradually and showed biphasic kinetics. Serum HBV pgRNA levels in patients treated with entecavir became negative later than those treated with adefovir or lamivudine. Patients who remain positive for HBV pgRNA after 9 years of treatment may have higher viral transcription efficiencies. The reverse transcription efficiency of hepatitis B e-antigen (HBeAg)-positive patients was higher than that of HBeAg-negative patients at baseline and showed no difference after 24-week nucleos(t)ide analog treatment. The trajectory of serum HBV pgRNA-negative transformation differs in patients with different characteristics. Long-term dynamic monitoring of serum HBV pgRNA levels has significance in hepatitis B treatment.
first_indexed 2024-04-14T06:58:19Z
format Article
id doaj.art-99a74b7c877d4b8d9a627ae66cae6bba
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-04-14T06:58:19Z
publishDate 2022-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-99a74b7c877d4b8d9a627ae66cae6bba2022-12-22T02:06:49ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2022-04-01910.3389/fmed.2022.851717851717Dynamics of Hepatitis B Virus Pregenomic RNA in Chronic Hepatitis B Patients With Antiviral Therapy Over 9 YearsJiali Pan0Yu Tian1Jinghang Xu2Hao Luo3Ning Tan4Yifan Han5Qian Kang6Hongyu Chen7Yuqing Yang8Xiaoyuan Xu9Department of Infectious Diseases, Peking University First Hospital, Beijing, ChinaDepartment of Gastroenterology, Peking University First Hospital, Beijing, ChinaDepartment of Infectious Diseases, Peking University First Hospital, Beijing, ChinaDepartment of Gastroenterology, National Center of Gerontology, Beijing Hospital, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Infectious Diseases, Peking University First Hospital, Beijing, ChinaDepartment of Infectious Diseases, Peking University First Hospital, Beijing, ChinaDepartment of Infectious Diseases, Peking University First Hospital, Beijing, ChinaDepartment of Infectious Diseases, Peking University First Hospital, Beijing, ChinaDepartment of Infectious Diseases, Peking University First Hospital, Beijing, ChinaDepartment of Infectious Diseases, Peking University First Hospital, Beijing, ChinaSerum hepatitis B virus pregenomic RNA (HBV pgRNA) is a potential biomarker that is correlated with covalently closed circular DNA. The long-term dynamics of HBV pgRNA in patients with chronic hepatitis B need to be explored. One hundred naïve nucleos(t)ide analog-treated patients with chronic hepatitis B were enrolled to analyze the dynamics of HBV pgRNA over 9 years. The positive rates of HBV pgRNAs declined gradually and showed biphasic kinetics. Serum HBV pgRNA levels in patients treated with entecavir became negative later than those treated with adefovir or lamivudine. Patients who remain positive for HBV pgRNA after 9 years of treatment may have higher viral transcription efficiencies. The reverse transcription efficiency of hepatitis B e-antigen (HBeAg)-positive patients was higher than that of HBeAg-negative patients at baseline and showed no difference after 24-week nucleos(t)ide analog treatment. The trajectory of serum HBV pgRNA-negative transformation differs in patients with different characteristics. Long-term dynamic monitoring of serum HBV pgRNA levels has significance in hepatitis B treatment.https://www.frontiersin.org/articles/10.3389/fmed.2022.851717/fullchronic hepatitis BPgRNAhepatitis B virusdynamicstranscription
spellingShingle Jiali Pan
Yu Tian
Jinghang Xu
Hao Luo
Ning Tan
Yifan Han
Qian Kang
Hongyu Chen
Yuqing Yang
Xiaoyuan Xu
Dynamics of Hepatitis B Virus Pregenomic RNA in Chronic Hepatitis B Patients With Antiviral Therapy Over 9 Years
Frontiers in Medicine
chronic hepatitis B
PgRNA
hepatitis B virus
dynamics
transcription
title Dynamics of Hepatitis B Virus Pregenomic RNA in Chronic Hepatitis B Patients With Antiviral Therapy Over 9 Years
title_full Dynamics of Hepatitis B Virus Pregenomic RNA in Chronic Hepatitis B Patients With Antiviral Therapy Over 9 Years
title_fullStr Dynamics of Hepatitis B Virus Pregenomic RNA in Chronic Hepatitis B Patients With Antiviral Therapy Over 9 Years
title_full_unstemmed Dynamics of Hepatitis B Virus Pregenomic RNA in Chronic Hepatitis B Patients With Antiviral Therapy Over 9 Years
title_short Dynamics of Hepatitis B Virus Pregenomic RNA in Chronic Hepatitis B Patients With Antiviral Therapy Over 9 Years
title_sort dynamics of hepatitis b virus pregenomic rna in chronic hepatitis b patients with antiviral therapy over 9 years
topic chronic hepatitis B
PgRNA
hepatitis B virus
dynamics
transcription
url https://www.frontiersin.org/articles/10.3389/fmed.2022.851717/full
work_keys_str_mv AT jialipan dynamicsofhepatitisbviruspregenomicrnainchronichepatitisbpatientswithantiviraltherapyover9years
AT yutian dynamicsofhepatitisbviruspregenomicrnainchronichepatitisbpatientswithantiviraltherapyover9years
AT jinghangxu dynamicsofhepatitisbviruspregenomicrnainchronichepatitisbpatientswithantiviraltherapyover9years
AT haoluo dynamicsofhepatitisbviruspregenomicrnainchronichepatitisbpatientswithantiviraltherapyover9years
AT ningtan dynamicsofhepatitisbviruspregenomicrnainchronichepatitisbpatientswithantiviraltherapyover9years
AT yifanhan dynamicsofhepatitisbviruspregenomicrnainchronichepatitisbpatientswithantiviraltherapyover9years
AT qiankang dynamicsofhepatitisbviruspregenomicrnainchronichepatitisbpatientswithantiviraltherapyover9years
AT hongyuchen dynamicsofhepatitisbviruspregenomicrnainchronichepatitisbpatientswithantiviraltherapyover9years
AT yuqingyang dynamicsofhepatitisbviruspregenomicrnainchronichepatitisbpatientswithantiviraltherapyover9years
AT xiaoyuanxu dynamicsofhepatitisbviruspregenomicrnainchronichepatitisbpatientswithantiviraltherapyover9years